Attenuvax
- Generic Name: measles virus vaccine live
- Brand Name: Attenuvax
Attenuvax (Measles Virus Vaccine Live) side effects drug center
Attenuvax Side Effects Center
Attenuvax (measles virus) Vaccine Live is an immunization used against measles (rubeola). Common side effects of Attenuvax include:
- injection site reactions (redness, burning, stinging, swelling, blistering, or hives)
- headache
- dizziness
- irritability
- fussiness
- excessive crying
- low fever
- cough
- runny nose
- joint or muscle pain
- nausea
- vomiting, or
- diarrhea
The dose of Attenuvax for any age is 0.5 mL administered subcutaneously, preferably into the outer aspect of the upper arm. The recommended age for primary vaccination is 12 to 15 months. Attenuvax may interact with steroids, medicines to treat or prevent organ transplant rejection, or medications to treat psoriasis, rheumatoid arthritis, or other autoimmune disorders. Tell your doctor all medications and supplements you use and all vaccines you recently received. Avoid becoming pregnant for at least 3 months after receiving a measles virus vaccine. Consult your doctor before breastfeeding.
Our Attenuvax (measles virus) Vaccine Live Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Attenuvax Consumer Information
Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).
You should not receive a booster vaccine if you had a life-threatening allergic reaction after the first shot.
Keep track of any and all side effects you have after receiving this vaccine. When you receive a booster dose, you will need to tell the doctor if the previous shots caused any side effects.
Becoming infected with measles, mumps, or rubella is much more dangerous to your health than receiving this vaccine. However, like any medicine, this vaccine can cause side effects but the risk of serious side effects is extremely low.
Call your doctor at once if you have any of these serious side effects:
- red, tender bumps under your skin;
- a light-headed feeling, like you might pass out;
- high fever (within a few hours or a few days after the vaccine);
- easy bruising or bleeding;
- new or worsening cough, trouble breathing;
- problems with balance or muscle movement;
- a seizure; or
- nervous system problems--numbness, pain, tingling, weakness, burning or prickly feeling, vision or hearing problems, trouble breathing.
You may have joint pain 2 to 4 weeks after receiving an MMR vaccine. This is more common in women and teenaged girls.
Common side effects include:
- headache, dizziness;
- nausea, vomiting, diarrhea.
- runny nose, sore throat, not feeling well;
- muscle pain, joint pain or stiffness; or
- feeling irritable (fussiness in a young child).
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report vaccine side effects to the US Department of Health and Human Services at 1-800-822-7967.
Read the entire detailed patient monograph for Attenuvax (Measles Virus Vaccine Live)
Attenuvax Professional Information
SIDE EFFECTS
The following adverse reactions are listed in decreasing order of severity, without regard to causality, within each body system category and have been reported during clinical trials, with use of the marketed vaccine, or with use of polyvalent vaccine containing measles:
Body as a Whole
Panniculitis; atypical measles; fever; syncope; headache; dizziness; malaise; irritability.
Cardiovascular System
Digestive System
Hemic and Lymphatic System
Thrombocytopenia (see WARNINGS, Thrombocytopenia); purpura; lymphadenopathy; leukocytosis.
Immune System
Anaphylaxis and anaphylactoid reactions have been reported as well as related phenomena such as angioneurotic edema (including peripheral or facial edema) and bronchial spasm in individuals with or without an allergic history.
Musculoskeletal
Nervous System
Encephalitis; encephalopathy; measles inclusion body encephalitis (MIBE) (see CONTRAINDICATIONS); subacute sclerosing panencephalitis (SSPE); Guillain-Barré syndrome (GBS); febrile convulsions; afebrile convulsions or seizures; ataxia; ocular palsies.
Experience from more than 80 million doses of all live measles vaccines given in the U.S. through 1975 indicates that significant central nervous system reactions such as encephalitis and encephalopathy, occurring within 30 days after vaccination, have been temporally associated with measles vaccine very rarely.28 In no case has it been shown that reactions were actually caused by vaccine. The Centers for Disease Control and Prevention has pointed out that “a certain number of cases of encephalitis may be expected to occur in a large childhood population in a defined period of time even when no vaccines are administered”.29 However, the data suggest the possibility that some of these cases may have been caused by measles vaccines. The risk of such serious neurological disorders following live measles virus vaccine administration remains far less than that for encephalitis and encephalopathy with natural measles (one per two thousand reported cases).30
Post-marketing surveillance of the more than 200 million doses of M-M-R and M-M-R II that have been distributed worldwide over 25 years (1971-1996) indicates that serious adverse events such as encephalitis and encephalopathy continue to be rarely reported.10
There have been reports of subacute sclerosing panencephalitis (SSPE) in children who did not have a history of natural measles but did receive measles vaccine. Some of these cases may have resulted from unrecognized measles in the first year of life or possibly from the measles vaccination. Based on estimated nationwide measles vaccine distribution, the association of SSPE cases to measles vaccination is about one case per million vaccine doses distributed. This is far less than the association with natural measles, 6-22 cases of SSPE per million cases of measles. The results of a retrospective case-controlled study conducted by the Centers for Disease Control and Prevention suggest that the overall effect of measles vaccine has been to protect against SSPE by preventing measles with its inherent higher risk of SSPE.31
Respiratory System
Pneumonitis (see CONTRAINDICATIONS); cough; rhinitis.
Skin
Stevens-Johnson syndrome; erythema multiforme; urticaria; rash.
Local reactions including burning/stinging at injection site; wheal and flare; redness (erythema); swelling; vesiculation at injection site.
Special Senses — Ear
Special Senses — Eye
Retinitis; optic neuritis; papillitis; retrobulbar neuritis; conjunctivitis.
Other
Death from various, and in some cases unknown, causes has been reported rarely following vaccination with measles, mumps, and rubella vaccines; however, a causal relationship has not been established. No deaths or permanent sequelae were reported in a published post-marketing surveillance study in Finland involving 1.5 million children and adults who were vaccinated with M-M-R II during 1982-1993.32
Under the National Childhood Vaccine Injury Act of 1986, health care providers and manufacturers are required to record and report certain suspected adverse events occurring within specific time periods after vaccination. However, the U.S. Department of Health and Human Services (DHHS) has established a Vaccine Adverse Event Reporting System (VAERS) which will accept all reports of suspected events.28 A VAERS report form as well as information regarding reporting requirements can be obtained by calling VAERS 1-800-822-7967.
Read the entire FDA prescribing information for Attenuvax (Measles Virus Vaccine Live)
© Attenuvax Patient Information is supplied by Cerner Multum, Inc. and Attenuvax Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.